CREBBP and chronic myelogenous leukemia, BCR-ABL1 positive: No. U85962) showed that CBP (p=0.002) and β-catenin (p=0.001) expression was significantly up-regulated in 76 cases of CML samples compared with 74 cases of normal samples (Figure 1A).